Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2003
07/10/2003US20030129242 Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
07/10/2003US20030129241 Effective amount of a vasoactive prostaglandin, a polysaccharide thickener, a lipophilic component, and an acidic buffer system
07/10/2003US20030129240 Polyoxyalkylene block copolymer at desired concentrations with or without a therapeutic agent
07/10/2003US20030129239 Water soluble nanoparticles of hydrophilic and hydrophobic active materials and an apparatus and method for their production
07/10/2003US20030129238 Edible, hardenable, prompt release coating of microcrystalline cellulose (mcc), a film forming propylene glycol alginate (pga), a strengthening polymer and a plasticizer, a surface active agent and a filler
07/10/2003US20030129237 Multiparticulate modified release composition
07/10/2003US20030129236 Clindamycin released in a first pulse, within thirty minutes of administration, and a second pulse 4-15 hours after
07/10/2003US20030129235 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
07/10/2003US20030129234 Methods of making sustained release formulations of oxymorphone
07/10/2003US20030129233 Sustained release hydrophobic bioactive PLGA microspheres
07/10/2003US20030129232 Biologically absorbable polyhydroxycarboxylic acid and production method thereof
07/10/2003US20030129231 Carrier causes oxycodone hydrochloride to preferentially release the drug in gastric fluid; analgesics
07/10/2003US20030129230 Sustained release formulations of oxymorphone
07/10/2003US20030129229 Pulse dosage formulations of methylphenidate and method to prepare same
07/10/2003US20030129228 Magnesium plus interactive agent delivery
07/10/2003US20030129227 Beta-lactam antibiotic-containing tablet and production thereof
07/10/2003US20030129226 Water soluble polymer-based rapidly dissolving tablets and production processes thereof
07/10/2003US20030129225 Topical formulations of natamycin/pimaricin
07/10/2003US20030129224 Liposomes containing a vesicle forming lipid and an aggreagation preventing component free of cholesterol, and the liposomes contain an encapsulated anticancer drug; osmolarity of intraliposomal aqueous medium =< 500 mOsm/kg less
07/10/2003US20030129222 Administering to a cancer patient a therapeutically effective amount of imexon or derivative in combination with one or more lipids to treat the cancer
07/10/2003US20030129221 A mixture of lipids containing a protonatable or deprotonatable lipid, such as polyoxyethylene glycol or polyamide oligomer modified lipid, or amino lipid is combined with a buffered aqueous solution of a charged drug
07/10/2003US20030129220 Transdermal administration of androgenic drugs using hydroxide-releasing agents as permeation enhancers
07/10/2003US20030129219 Self-emulsifying matrix type trandermal preparation
07/10/2003US20030129211 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
07/10/2003US20030129209 Topical application of cetirizine and loratadine
07/10/2003US20030129182 Contacting vitreous humor with beta-glucuronidase, matrix metalloproteinase, chondroitinase, chondroitin sulfatase, and/or protein kinase; thimerosal-free
07/10/2003US20030129172 Animal growth regulator
07/10/2003US20030129156 Use of a polypeptide for treatment of pruritis in animals
07/10/2003US20030129145 Aftersmoking; converting nicotine to cotinine; discharing in urine
07/10/2003US20030129141 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery
07/10/2003US20030129140 In situ infection therapy; aminoglycoside antibiotics
07/10/2003US20030129139 Drug delivery; lightweight hollow spheres; spray drying
07/10/2003US20030129137 Stable microbubble suspensions as enhancement agents for ultrasound echography
07/10/2003US20030129130 Drug delivery; microparticles immobilized on polymer surface
07/10/2003US20030127760 Apparatus and methods for forming patterned soft gelatin capsules
07/10/2003US20030127207 Antimicrobially-treated fabrics
07/10/2003CA2511902A1 Seal oil based lipid emulsions and uses thereof
07/10/2003CA2472401A1 Improved method of production of lycopene by the fermentation of selected strains of blakeslea trispora, formulations and uses of the lycopene obtained
07/10/2003CA2471903A1 Micronized pharmaceutical or nutraceutical powder with immediate release
07/10/2003CA2471798A1 Adhesive transdermal formulations of diclofenac sodium
07/10/2003CA2471300A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
07/10/2003CA2471039A1 Method of systemically delivering ssris
07/10/2003CA2470684A1 A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
07/10/2003CA2470545A1 Heteroxylan film-forming composition for making capsules and resulting capsules
07/10/2003CA2470511A1 Liquid composition of factor vii polypeptides
07/10/2003CA2469214A1 Improved polymer-lipid delivery vehicles
07/10/2003CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003CA2463738A1 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
07/10/2003CA2416030A1 Sedative non-benzodiazepine formulations
07/09/2003EP1325765A1 Combinations of Formoterol and Mometasone Furoate for Asthma
07/09/2003EP1325757A1 Embolic materials
07/09/2003EP1325753A2 Bio-compatible means for controlled drug delivery to tissue and method of use
07/09/2003EP1325752A2 Composition for transdermal and/or transmucosal administration of active compounds which ensures adequate therapeutic levels
07/09/2003EP1325746A1 Controlled release oxycodone compositions
07/09/2003EP1325742A1 Improved transdermal therapeutic system for the treatment of Parkinson's disease
07/09/2003EP1325741A2 Implantable delivery device with self adjustable exit port
07/09/2003EP1325740A1 Stable granulates containing S-Adenosylmethionine and process for the preparation thereof
07/09/2003EP1325739A1 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors
07/09/2003EP1325116A2 Isoprenoid-dependent ras anchorage (idra) proteins
07/09/2003EP1325046A1 Zwitterionic polymers
07/09/2003EP1325044A1 Aqueous polymer dispersion
07/09/2003EP1325035A1 Starch
07/09/2003EP1325034A1 Pharmaceutically acceptable starch
07/09/2003EP1324972A1 Dihydroxy open-acid salt of simvastatin
07/09/2003EP1324797A2 Medicament dispenser
07/09/2003EP1324789A2 Fluid material dispensing syringe
07/09/2003EP1324782A2 Stabilized hydrogen peroxide solutions
07/09/2003EP1324776A2 Reduced-viscosity concentrated protein formulations
07/09/2003EP1324769A2 Split enveloped virus preparation for intranasal delivery
07/09/2003EP1324760A1 Creatine ester pronutrient compounds and formulations
07/09/2003EP1324758A1 Method for preparing microspheres containing a water-soluble substance
07/09/2003EP1324755A1 Pharmaceutical solutions of modafinil compounds
07/09/2003EP1324753A2 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases
07/09/2003EP1324752A2 Delayed release pharmaceutical formulations
07/09/2003EP1324750A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
07/09/2003EP1324749A2 Medicinal aerosol formulations
07/09/2003EP1324748A1 Topical antibiotic composition for treatment of eye infection
07/09/2003EP1231896A4 Taste masked oral compositions
07/09/2003EP1175210A4 Increasing cerebral bioavailability of drugs
07/09/2003EP1173151B1 Dry, mouldable drug formulation
07/09/2003EP1165051B1 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
07/09/2003EP1143929B1 BIODEGRADABLE pH/THERMOSENSITIVE HYDROGELS FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS
07/09/2003EP1035862B1 Cyclosporin-containing microemulsion preconcentrate composition
07/09/2003EP1031345B1 Gel preparation containing polystyrene-sulfonates
07/09/2003EP1028706B1 Buffered drug formulations for transdermal electrotransport delivery
07/09/2003EP1009385B1 Cholesterol level lowering composition
07/09/2003EP1007015B1 In situ formation of polymeric material
07/09/2003EP0994703B1 Composition comprising ketanserin and l-carnitine for the treatment of crps
07/09/2003EP0975326B1 Topical application of enzymes using a peelable film
07/09/2003EP0964690B1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
07/09/2003EP0790823B1 Drug releasing surgical implant or dressing material
07/09/2003EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
07/09/2003EP0612242B1 Use of the pure s(+) isomer of fluoxetine for the preparation of a medicament against migraine headache
07/09/2003EP0573576B2 Compositions for topical administration of pharmaceutically active agents
07/09/2003EP0190315B2 Dehydrated liposomes
07/09/2003CN1429220A Crystalline base of citalopram
07/09/2003CN1429205A 磺酰胺衍生物 Sulfonamide derivatives
07/09/2003CN1429120A Stable polymeric micelle-type drug composition and method for preparation thereof
07/09/2003CN1429119A Method for preparation of polymeric micelle via separation of block copolymer
07/09/2003CN1429116A Pharmaceutical composition